Kestra Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Kestra Advisory Services's ALNY Position: Q2 2026 in Review
Kestra Advisory Services increased its Alnylam Pharmaceuticals (ALNY) stake by 129% in Q2 2026, buying an estimated $461K and bringing the position to 2,711 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #1981.
Kestra Advisory Services first reported a position in ALNY in Q3 2020 and has held it in 19 quarters since. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Kestra Advisory Services held 2,711 shares of Alnylam Pharmaceuticals worth $816K as of Q2 2026.
- Kestra Advisory Services bought 1,527 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $461K.
- Alnylam Pharmaceuticals made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #1981 holding.
- Kestra Advisory Services first reported a position in Alnylam Pharmaceuticals in Q3 2020 and has held it in 19 quarters since.
- 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.